Patent Yard Sign in
Expired Canadian patentCanada

Production of a monoclonal antibody by a transgenic avian

CA 2436754 C · Owner: Rapp, Jeffrey C. · Inventors: Rapp, Jeffrey C.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates generally to novel methods of producing transgenic chickens that generate antibodies or immunoglobulin polypeptides in whites of eggs. More specifically, one embodiment of the present invention relates to methods of inserting immunoglobulin-encoding transgenes into avian sperm cells for transfer to ova to generate transgenic zygotes. The transgenes may include at least two immunoglobulin-encoding nucleic acid sequences and an internal ribosome entry site (IRES) that allow the immunoglobulin polypeptides to be expressed by chicken cells and hence in egg whites.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 28, 2002 and granted January 24, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 28, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 28, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 28, 2002
GrantedJanuary 24, 2012
Term endedJanuary 28, 2022
Patent numberCA 2436754 C
Classification (IPC)C12P21/08 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJan 28, 2002Patent grantedJan 24, 2012Term endedJan 28, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.